Kinetic analysis of the early signaling steps of the human chemokine receptor CXCR4 by Perpina-Viciano, C. et al.
1521-0111/98/2/72–87$35.00 https://doi.org/10.1124/mol.119.118448
MOLECULAR PHARMACOLOGY Mol Pharmacol 98:72–87, August 2020
Copyright ª 2020 by The Author(s)
This is an open access article distributed under the CC BY-NC Attribution 4.0 International license.
Kinetic Analysis of the Early Signaling Steps of the Human
Chemokine Receptor CXCR4 s
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ABSTRACT
G protein–coupled receptors (GPCRs) are biologic switches that
transduce extracellular stimuli into intracellular responses in the
cell. Temporally resolving GPCR transduction pathways is key to
understanding how cell signaling occurs. Here, we investigate
the kinetics and dynamics of the activation and early signaling
steps of the CXC chemokine receptor (CXCR) 4 in response to its
natural ligands CXC chemokine ligand (CXCL) 12 and macro-
phage migration inhibitory factor (MIF), using Förster resonance
energy transfer–based approaches. We show that CXCR4
presents a multifaceted response to CXCL12, with receptor
activation (0.6 seconds) followed by a rearrangement in the
receptor/G protein complex (1 seconds), a slower dimer
rearrangement (1.7 seconds), and prolonged G protein
activation (4 seconds). In comparison, MIF distinctly mod-
ulates every step of the transduction pathway, indicating
distinct activation mechanisms and reflecting the different
pharmacological properties of these two ligands. Our study
also indicates that CXCR4 exhibits some degree of ligand-
independent activity, a relevant feature for drug development.
SIGNIFICANCE STATEMENT
The CXC chemokine ligand (CXCL) 12/CXC chemokine receptor
(CXCR) 4 axis represents a well-established therapeutic target
for cancer treatment. We demonstrate that CXCR4 exhibits
a multifaceted response that involves dynamic receptor dimer
rearrangements and that is kinetically embedded between
receptor–G protein complex rearrangements and G protein
activation. The alternative endogenous ligand macrophage
migration inhibitory factor behaves opposite to CXCL12 in
each assay studied and does not lead to G protein activation.
This detailed understanding of the receptor activation may aid
in the development of more specific drugs against this target.
Introduction
G protein–coupled receptors (GPCRs) transduce signals of
diverse nature from the extracellular side into specific
responses within the cell through a succession of biochem-
ical events. Generally, binding of an agonist to a receptor
causes structural changes in the transmembrane (TM)
helices that stabilize the receptor in an active conformation.
This is followed by interaction with and subsequent activa-
tion of heterotrimeric G proteins, which modulate the
activity of different downstream effectors. Receptors can
then be phosphorylated by kinases and internalized, result-
ing in degradation or recycling to the plasma membrane
(Hilger et al., 2018).
Crystal structure analysis has provided enormous insights
into the molecular mechanisms involved in GPCR activation.
However, the detailed temporal dynamics of these changes
cannot be resolved in these studies. In this aspect, the use of
Förster resonance energy transfer (FRET)-based approaches
represents a tool to investigate the dynamics and kinetics of
GPCR activation and their downstream signaling events in
real time and in intact cells (Lohse et al., 2012). The most
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common structural characteristic of receptor activation is
a large outward shift of the intracellular part of TM domain
VI (Altenbach et al., 2008). This unique feature has been the
basis for the development of FRET sensors formany receptors,
which can report ligand-induced structural rearrangements in
a temporal manner (Lohse et al., 2014; Stumpf and Hoffmann,
2016; Wright et al., 2018). These sensors together with other
FRET-based approaches have helped to understand the
distinct mechanisms of activation between different ligand
types (Vilardaga et al., 2005), allosterism (Messerer et al.,
2017), and receptor classes (Vilardaga et al., 2003). Most
studies have found activation time constants of monomeric
GPCRs on the order of 30–50 milliseconds (Hoffmann et al.,
2005; Rochais et al., 2007; Reiner et al., 2010; Ziegler et al.,
2011). However, there are apparent differences between
various receptor types. Thus, activation of class B parathyroid
hormone receptor (PTHR) 1 by its large agonist PTH(1–34) is
about 20-fold slower (Vilardaga et al., 2003). Another specific
case is the activation in dimeric receptors. In a recent study
aiming at resolving rapid activation steps of metabotropic
glutamate receptors (mGluRs), it was shown that an initial
rearrangement of the dimer structure occurs within 1 to 2
milliseconds, whereas conformational changes in the 7-helix
TM structure occur within 20milliseconds (Grushevskyi et al.,
2019). Another open question regarding activation in receptor
dimers is how the two protomers influence each other. An
early study of a2-adrenergic/m-opioid heterodimers suggested
that in such a dimer only one of the two protomers is active
(Vilardaga et al., 2008). Likewise, initial studies of mGluRs
indicated that only one of the two protomers becomes acti-
vated (Hlavackova et al., 2005). However, it now appears clear
that activation of both protomers is required for full activation
(Kniazeff et al., 2004; Grushevskyi et al., 2019).
The CXC chemokine receptor (CXCR) 4 appears to be
a facultative homodimer, and dimer formation may contrib-
ute to its signaling function. CXCR4 and its cognate ligand
CXCL12, formerly known as stromal cell-derived factor-1,
are key players in cell migration in different contexts
(Alsayed et al., 2007; Yang et al., 2013). A two-step binding
mechanism of chemokines to their chemokine receptors has
been proposed (Qin et al., 2015). Binding of CXCL12
preferentially results in activation of Gi proteins as well
as b-arrestin recruitment (Heuninck et al., 2019). The
CXCR4/CXCL12 axis is an important therapeutic target
for the development of new drugs because of its involvement
in several types of cancer (Guo et al., 2016; Adlere et al.,
2019; Bobkov et al., 2019) in addition to the well-proven role
of CXCR4 as a human immunodeficiency virus coreceptor
(Tsibris and Kuritzkes, 2007). Recently, macrophage mi-
gration inhibitory factor (MIF) has also been demonstrated
to bind to CXCR4, but the binding mode and downstream
consequences observed greatly differ from those of CXCL12.
For instance, MIF binding to the receptor does not result in
b-arrestin recruitment (Bernhagen et al., 2007; Rajasekaran
et al., 2016; Lacy et al., 2018). The biomedical importance of
CXCR4 and its ligands, their dynamic monomer/dimer equi-
librium, the suggested two-step activation mechanism, and
the existence of several endogenous agonists with diverse
effects all make the spatio-temporal analysis of CXCR4
signaling particularly interesting.
Therefore, we set out to analyze the early steps of CXCR4
activation in response to the two distinct ligands CXCL12 and
MIF. We have combined several FRET approaches to eluci-
date the temporal aspects of the receptor-mediated early
signaling events with subsecond resolution. Our data show
that these two ligands modulate the receptor’s activity
oppositely and that, in the absence of agonist, CXCR4 exhibits
some degree of constitutive activity.
Materials and Methods
Plasmid DNA Constructs
Human CXCR4 with YFP fused to the C terminus was a kind gift of
F. Bachelerie (INSERM, Université Paris-Sud, France; Levoye et al.,
2009). The a2A-adrenergic receptor (AR) has been previously described
(Bünemann et al., 2003). The G protein subunits Gai1, Gai1–cyan
fluorescent protein (CFP), Gb1, Gg2, and Gg2-CFP and the a2A-AR-
YFP (labeled at the C terminus) have been previously described (Hein
et al., 2005). The G protein sensors for Gi1, Gi2, Gi3, and Gq have been
previously described (Adjobo-Hermans et al., 2011; Van Unen et al.,
2016). The cAMP-responsive element (CRE)-Luc construct has been
previously described (Watts et al., 2013).
Human CXCR4 and human CXCR4 with three hemagglutinin (HA)
tags fused to the N terminus (3HA-CXCR4) are in pcDEF3 (Vrije
Universiteit, Amsterdam, The Netherlands). The 3HA-CXCR4 con-
struct was employed to label the receptor with enhanced CFP (BD
Biosciences). For that, the fluorescent protein was fused in-frame to
the C terminus of CXCR4 by standard PCR extension overlap
technique. The C-terminal stop codon of the receptor and the initial
methionine codon of the fluorescent protein were deleted. The
resulting construct was named CXCR4-CFP and contained the
fluorescent protein after S352. To create the different receptor
sensors, the fluorescein arsenical hairpin binder (FlAsH)-binding
motif CCPGCC was inserted at different positions within the in-
tracellular loop-3 (ICL-3) of the receptor in the CXCR4-CFP construct:
between amino acids L226 and S227 (CXCR4-FlAsH226-CFP), be-
tween amino acids H228 and S229 (CXCR4-FlAsH228-CFP), or
between amino acids S229 and K230 (CXCR4-FlAsH229-CFP). Clon-
ing was performed using site-directed mutagenesis by overlap exten-
sion PCR. To create analogous constructs only containing the FlAsH-
binding motif in different positions of ICL-3 (CXCR4-FlAsH226,
CXCR4-FlAsH228, and CXCR4-FlAsH229), the CFP was removed
from the C terminus of the corresponding receptor sensors via
standard PCR.
The Pfu polymerase was used for amplifying DNA in the PCRs, and
the T4 ligase enzyme was used for ligation. Escherichia coli DH5a
(Invitrogen) was used as a host to clone all the genes described. All
constructs were verified by sequencing (Eurofins Genomix GmbH,
Germany).
Ligands
Recombinant human CXCL12 was purchased from Peprotech (300-
28A); recombinant human MIF was purchased from Peprotech (300-
69); norepinephrine was purchased from Sigma Aldrich (A9512); and
IT1twas purchased fromTocris (4596). AMD3100was purchased from
Sigma Aldrich (A5602), and CXCL12-AlexaFluor647 was from Almac
(CAF-11).
Cell Lines and Cell Culture
Human embryonic kidney cell 293 (HEK293) and HEK293T cell
lines (American Type Culture Collection) (CRL-1573 and CRL-3216)
were cultured using Dulbecco’s modified Eagle’s medium supple-
mented with 4.5 g/l glucose (Gibco), 10% (v/v) FBS (Biochrom),
1% penicillin/streptomycin (Gibco), and 1%L-glutamine (PanBiotech).
Cells were kept in a humidified 7% CO2 atmosphere at 37°C. For
routinemaintenance, cells were split every 2 or 3 days by rinsing them
with Dulbecco’s phosphate-buffered saline (DPBS) (Gibco) and then












trypsin-EDTA (PanBiotech). Cell lines were routinely tested for
mycoplasma contamination by PCR using a primer set specific for
the highly conserved 16S ribosomal RNA–coding region in the
mycoplasma genome. Cells have not been authenticated.
TheN-terminalNanoLuc (NLuc)-labeled CXCR4 receptor construct
was created from a previously described construct (Stoddart et al.,
2015) and was used for the binding competition assay. Briefly, the
adenosine A1 receptor cDNA was replaced with that encoding the
human CXCR4 (NM_003467.2). The resultant construct fused NLuc
in-frame with the membrane signal sequence from the 5-HT3A
receptor within pcDNA3.1 to generate signal-NLuc. The human
CXCR4 sequence (methionine start signal removed) was then fused
to the 39 end of signal-NLuc via a short Gly-Ser linker. Stable mixed-
expression populations of HEK293G cell lines [HEK293 expressing
the GloSensor (20F) cAMP biosensor; Promega Corporation] express-
ing the NLuc-CXCR4 cDNA construct were created by transfecting
cells with FuGENE HD (Promega Corporation) following the manu-
facturer’s instructions. Cells were then subject to antibiotic
selection using G418 disulfate salt (1 mg/ml; Sigma Aldrich) for 2
to 3 weeks, screened for luminescence expression, and expanded.
The HEK293G-NLuc-CXCR4 cell line was cultured using Dulbec-
co’s modified Eagle’s medium (Sigma Aldrich) supplemented with
10% FBS (Sigma Aldrich). Cells were kept in a humidified 5% CO2
atmosphere at 37°C. For routine maintenance, cells were split
every 2 or 3 days by using DPBS (Lonza) and trypsin-EDTA
(0.25% w/v versene; Lonza).
FlAsH Labeling
FlAsH labeling was done as previously described (Hoffmann et al.,
2010) right before the measurements. In brief, transfected cells grown
on 24-mm glass coverslips (Hartenstein, Würzburg, Germany) or
40-mmWillCo dishes (WillCo Wells) were washed twice with labeling
buffer (150mMNaCl, 10mMHEPES, 2.5mMKCl, 4mMCaCl2, 2mM
MgCl2 freshly supplemented with 1.8 g/l glucose; pH 7.3). Sub-
sequently, cells were incubated for 1 hour at 37°C with labeling buffer
containing 1 mM FlAsH (commercially available from Thermo Fisher
Scientific, Darmstadt, Germany as TC-FlAsH labeling kit) and
12.5 mM 1,2-ethanedithiol (Sigma Aldrich). Cells were rinsed twice
and incubated for 10 minutes at 37°C in labeling buffer containing
250 mM 1,2-ethanedithiol to reduce nonspecific FlAsH labeling.
Finally, cells were washed twice and kept in media at 37°C until
measurement.
Confocal Microscopy
HEK293 cells were seeded on 24-mm glass coverslips, which had
been previously coated with poly-D-lysine (1 mg/ml; MP Biomedicals)
for 30 minutes and washed once with DPBS, and placed in wells of
a six-well plate. After 6 hours, and for each well, cells were transfected
with 0.5 mg of the different CXCR4 sensors (CXCR4-FlAsH226-CFP,
CXCR4-FlAsH228-CFP, or CXCR4-FlAsH229-CFP) using Effectene
(Qiagen), following the manufacturer’s instructions. Prior to trans-
fection, the media of the cells was exchanged for fresh media. Cells
were analyzed 48 hours after transfection. When indicated, cells were
FlAsH-labeled right before the measurement. During the experiment,
cells were kept in imaging buffer (140 mM NaCl, 5.4 mM KCl, 2 mM
CaCl2, 1 mM MgCl2, 10 mM HEPES; pH 7.3).
Confocal microscopy was performed using a Leica TCS SP8 system
(Leica Microsystems, Germany) with an Attofluor holder (Molecular
Probes), and imageswere takenwith a 63water objective (numerical
aperture 1.4). CFP was excited with a diode laser line at 442 nm, and
fluorescence intensities were recorded from 470 to 550 nm. FlAsHwas
excited with an argon laser line at 514 nm, and fluorescence
intensities were recorded from 525 to 600 nm. Images were acquired
at 1024 1024–pixel format, line average 3 and 400Hz. To avoid bleed
through, parallel images of CFP and FlAsH were taken in sequential
scan. Images were analyzed using the Leica Application Suite
Advanced Fluorescence Software (Leica Microsystems).
Single-Cell FRET Experiments
Microscopic FRET Set-Up. FRET measurements were per-
formed on an inverted microscope (Zeiss Axiovert 200; Zeiss)
equipped with an oil immersion 63 objective lens and a dual-
emission photometric system (Till Photonics). The transfected cells
were excited with light from a polychrome IV (Till Photonics) at
a frequency of 10 Hz with 40 milliseconds illumination out of a total
time of 100 milliseconds. Emission of the donor (CFP or mTur-
quoise2; 480 6 20 nm) and acceptor (YFP, FlAsH, or Venus; 535 6
15 nm) and the FRET ratio (Facceptor/Fdonor) were monitored
simultaneously (beam splitter DCLP 505 nm) upon excitation at
436 6 10 nm (beam splitter DCLP 460 nm). Fluorescence signals
were detected by photodiodes, digitalized using an analog-digital
converter (Digidata 1440A; Axon Instruments), and stored with
Clampex 9.0 software (Molecular Devices, Sunnyvale, CA).
Determination of FRET Efficiency. Determination of the
FRET efficiency was performed as previously described (Jost et al.,
2008). HEK293 cells were prepared in 24-mm glass coverslips, as
described for confocal microscopy. To study the basal intramolecular
FRET, cells were transfected with 0.5 mg of CXCR4-FlAsH226-CFP,
CXCR4-FlAsH228-CFP, or CXCR4-FlAsH229-CFP sensor perwell. To
study the basal intermolecular FRET, cells were transfected with 0.3
mg of CXCR4-CFP and 0.3 mg of CXCR4-FlAsH228 per well. Trans-
fection was performed using Effectene. Prior to the measurement,
cells were FlAsH-labeled. Then, the coverslips were mounted on an
Attofluor holder and kept in 999 ml of imaging buffer. During the
measurement (after approximately 30 seconds of recording), 1 ml of
British anti-Lewisite (BAL) (Fluka) was added to yield a final BAL
concentration of 5 mM, which displaced FlAsH from its binding site in
the receptors’ ICL-3. The FRET efficiency was calculated by analyzing
the increase in the CFP emission [CFP fluorescence (FCFP)] due to
dequenching using the formula (FCFP,max2FCFP,min)/FCFP,max and the
Clampfit software (Molecular Devices). Data are shown as a scatter
plot with mean and S.D., in which each dot represents an individual
cell. At least three independent repeats were performed for each
condition.Measurementswere performed using themicroscopic FRET
set-up described above.
Kinetic Measurements. For kinetic experiments, HEK293 cells
were seeded on 40-mm WillCo dishes previously coated with poly-
D-lysine for 30 minutes and washed once with DPBS. Six hours
later, cells were transfected with the appropriate construct(s) using
Effectene. For measuring receptor activation, 0.7 mg of each sensor
(CXCR4-FlAsH226-CFP, CXCR4-FlAsH228-CFP, or CXCR4-FlAsH229-
CFP) were transfected per dish, and FlAsH labeling was performed
before the measurement. For receptor/G protein interaction studies,
0.6 mg of CXCR4-YFP, 0.7 mg of Gai1, 0.3 mg of Gb1, and 0.2 mg of Gg2-
CFP were transfected per dish. When indicated, 0.6 mg of CXCR4-
YFP, 0.7 mg of Gai1-CFP, 0.3 mg of Gb1, and 0.2 mg of Gg2 were
transfected instead. For measuring G protein activation, 0.4 mg of
receptor (CXCR4 or a2A-AR) or empty plasmid and 0.75mg of G protein
sensor (Gi1, Gi2 or Gi3) were transfected per dish. For measuring
rearrangements within dimers, 0.5 mg of CXCR4-CFP and 0.5 mg of
CXCR4-YFP were transfected per dish. Prior to transfection, the
media of the cells was exchanged for fresh media. FRET measure-
ments were performed 48 hours after transfection using the micro-
scopic FRET set-up.
During the experiments, cells were kept in imaging buffer. Then,
using the BioPen microfluidic system (Fluicell, Gothenburg, Sweden;
Ainla et al., 2010, 2012; Wright et al., 2018), single cells were exposed
to the different solutions, as follows: cells were initially washed
(approximately for 10–20 seconds) with imaging buffer to establish
a baseline. Then, cells were stimulatedwith buffer supplementedwith
the appropriate ligand (CXCL12, MIF, or norepinephrine) at the
indicated concentrations in the figures, until the response reached
a plateau. Then, cells were washed again with imaging buffer, ideally,
until reversal of the ligand-induced signal was observed (return to
baseline). When indicated, a second stimulation and wash-out were












performed. The duration of the stimuli is indicated in the figures as
horizontal black lines. All the solutions contained 0.1% bovine serum
albumin (BSA) (AppliChem).
For determining the kinetics of each process (t values; apparent on-
or off-rate), the FRET ratio of individual experiments was fitted to
a one-component exponential decay function using the Clampfit
software. For each case, t values are shown as a scatter plot with
median and interquartile range (IQR), in whichN is the total number
of individual cells measured in several independent experiments, as
indicated in the figure legends.When required, statistical significance
was tested using Mann-Whitney test or Kruskal-Wallis test. For
determining the amplitude of the signals, maximum and minimum
values were considered, and data are reported as mean 6 S.E.M.
The emission of the acceptor fluorophores was corrected for that
attributable to bleed through (spillover of donor into the 535-nm
channel) and direct excitation (acceptor emission at 436 nm excita-
tion). FRET was normalized and corrected for photobleaching.
Processing of the data were done with OriginPro 2016 (OriginLab
Corporation, Northampton, MA).
Acceptor Photobleaching Experiments. HEK293 cells were
prepared in 24-mm glass coverslips as previously described for
confocal microscopy. Six hours later, cells were transfected with 0.6
mg of CXCR4-YFP or a2A-AR-YFP, 0.7mg of Gai1, 0.3mg of Gb1, and 0.2
mg of Gg2-CFP, per dish, using Effectene. Prior to transfection, the
media of the cells was exchanged for fresh media. FRET measure-
ments were performed 48 hours after transfection using the micro-
scopic FRET set-up. For the experiment, CFP and YFP fluorescence
intensities were measured at 10 Hz for 40 seconds with 20 milli-
seconds illumination out of a total time of 100 milliseconds. Then, the
donorwas photobleached by illuminating for 9minutes at 490 nmwith
90 milliseconds illumination out of a total time of 100 milliseconds.
Subsequently, the CFP and YFP fluorescence intensities were mea-
sured again for 40 seconds with 20 milliseconds illumination out of
a total time of 100 milliseconds. During the measurements, cells were
kept in 600 ml of imaging buffer. When indicated, cells expressing
CXCR4 and the G protein subunits were pretreated with media
containing 10 mM IT1t for 4 hours and kept in 600 ml imaging buffer
containing 10 mM IT1t during the measurement. The change in the
FCFP was calculated by considering the values of CFP fluorescence
right before and after the bleaching process, using the formula
[(FCFP,after 2 FCFP,before)/FCFP,after] and the Clampfit software. For
each condition, three independent repeats were performed. Data are
shown as a box plot in which the whiskers represent maximum and
minimum values. Statistical significance between groups was tested
using unpaired t test.
CRE-Luc Reporter-Gene Assay
The signaling properties of the different CXCR4 constructs were
characterizedusing aCRE-driven reporter-geneassay.HEK293Tcells
were transfectedwith the CXCR4 constructs (CXCR4, CXCR4-CFP, or
CXCR4-FlAsH228-CFP) and the CRE-Luc construct using 25-kDa
linear polyethylenimine (PEI) (Polysciences) as DNA carrier agent in
a 1:10 ratio (DNA/PEI). For transfection, 2 mg of DNA were combined
with 12 mg of PEI in a total volume of 250 ml 150 mM NaCl and
incubated for 20 minutes at room temperature. Then, 1 million
resuspended cells were added to the DNA/PEI mix, and 80 ml were
seeded at a density of 32,000 cells/well in a white, flat-bottom 96-well
plate (Greiner Bio One). Analysis was done 24 hours after seeding the
cells using Mithras LB940 (Berthold Technologies).
The day of the measurement, cells were incubated in media or
media supplementedwith 1mM forskolin (FSK) (LCLaboratories) and
increasing concentrations of CXCL12 (as indicated in the figure) and
incubated for 6 hours at 37°C. Subsequently, the media was substituted
for 25 ml of luciferase assay reagent [45 mM Tris H3PO4 pH 7.8,
45% glycerol, 3% Triton X-100, 1 mM DTT, 20 mM MgCl2, 800 mM
D-Luciferin (Duchefa), 80mMATP]and incubated20minutes in thedark.
Finally, the plate luminescence was measured and quantified.
The data from concentration-response curves were fitted to a three-
parameter sigmoidal model using GraphPad. For each construct
tested, four independent experiments were performed in quadrupli-
cate. Means of EC50 values and asymmetric 95% confidence interval
(CI) are reported in the text and have been calculated based on the
logarithmic values (logEC50).
Binding Competition Assay
Twenty-four hours prior to assay, HEK293G cells stably expressing
NLuc-CXCR4 were seeded on poly-D-lysine–coated white flat-bottom
96-well plates at a density of 40,000 cells/well. On the day of the assay,
plating medium was removed and replaced with Hanks’ balanced salt
solution/0.1% protease-free BSA (Hanks’ balanced salt solution
composition 10 mM HEPES, 146 mM NaCl, 5 mM KCl, 1 mM
MgS04, 2 mM sodium pyruvate, 1.3 mM CaCl2, and 1.5 mM NaHCO3;
pH 7.4 with the addition of 10 mM glucose after autoclaving). A fixed
concentration of the fluorescent ligand CXCL12-AlexaFluor647
(10 nM) was added simultaneously in triplicate wells, alongside
increasing concentrations of unlabeled CXCL12, AMD3100, or MIF
for 120 minutes at 37°C. The NLuc substrate was then added (50
dilution), and plates were left to equilibrate in the dark for 5 minutes.
Sequential dual luminescence and fluorescence readings were
recorded using a PHERAstar FS plate reader (BMG Labtech,
Germany) with 460 nm (80-nm bandpass; donor NLuc emission) and
.610 nm longpass filters (acceptor CXCL12-AF647 emission). Raw
bioluminescence resonance energy transfer ratios were calculated
from the ratio of acceptor to donor emission values. Data were fitted to
a three-parameter sigmoidal model using GraphPad. Data were
pooled from five-sixths independent experiments (six independent
experimentswithCXCL12 andMIF ligands, of which five experiments
also used AMD3100) and are expressed as mean 6 S.E.M.
G Protein Activation in 96-Well Plates
HEK293T cells were seeded in 100-mm plates and grown until they
reached 60%–65% confluency. Then, cells were transfectedwith 1.5mg
of receptor (CXCR4, CXCR4-FlAsH226, CXCR4-FlAsH228, or
CXCR4-FlAsH229) and 3 mg of FRET-based G protein sensor (Gi1,
Gi2, Gi3, or Gq) plasmid using Effectene. When indicated, empty
plasmid was transfected instead of receptor. Prior to transfection, the
media of the cells were replaced by fresh media. Twenty-four hours
after transfection, cells were harvested in culturemedia and seeded at
a density of 30,000 cells/well in black flat-bottom 96-well plates
(Brand). The plates had been preincubated with poly-D-lysine
(1 mg/ml) for 30 minutes and washed once with DPBS. Analysis
was done 24 hours after seeding the cells.
To generate concentration-response curves in a microplate reader,
cells were incubated at 37°C over 30 minutes with 90 ml of imaging
buffer containing 0.1% BSA. Afterward, the fluorescence was read for
5 minutes to determine the preread signal. After the reading, 10 ml of
buffer or increasing concentrations of CXCL12 (indicated in the figure)
were added to thewells for a total assay volume of 100ml. Fluorescence
was read again for 20 minutes to determine the postread signal.
During the measurement, cells were kept at 37°C. CXCL12 was
prepared in imaging buffer containing 0.1% BSA. The FRET change
produced by each concentration of ligand tested was corrected for the
signal obtained in vehicle (nonligand; buffer)-treated cells. To de-
termine the EC50 values for G protein activation, data were fitted to
a three-parameter sigmoidal model using GraphPad. N = 5 indepen-
dent experiments performed in quadruplicate. Means of EC50 values
and asymmetric 95% CI are reported in the text and have been
calculated based on the logarithmic values (logEC50). Statistical
significance was tested using one-way ANOVA followed by Tukey’s
test on the logEC50 values.
To investigate basal G protein activity, HEK293T cells trans-
fected with CXCR4 and the Gi2 sensor were seeded at a density of
15,000 cells/well after the same protocol as described above for
concentration-response curves. Three different conditions were












analyzed in parallel: 1) buffer, 2) IT1t treatment, and 3) CXCL12
treatment. For 1), cells were incubated with 100 ml of imaging buffer
for 4 hours. For 2), cells were incubated with 100 ml of imaging buffer
supplemented with 100 mM IT1t for 4 hours. For 3), cells were
incubated with 90 ml of imaging buffer for 4 hours, and 2 minutes
before the measurement, 10 ml of 1 mM CXCL12 were added (final
CXCL12 concentration: 100 nM). All the solutions contained
0.1% BSA. After the treatments, fluorescence was read for 8 minutes.
The FRET detected under the three different conditions was normal-
ized to “buffer treatment,” which was set to 100. Three independent
repeats were performed in quadruplicate. Data are shown as a bar
graph with S.D. Statistical significance between groups was tested
using unpaired t test.
Experiments were performed using Synergy Neo2 Multi-Mode
Microplate Reader (Biotek) with Gen5 Data Analysis Software.
During the measurements, cells were excited at 420/50 nm (Biotek
CFP-YFP Filter; 1035013), and emission wasmonitored at 485/20 and
540/25 nm (Biotek CFP-YFP Filter; 1035043).
Quantification and Statistical Analysis
Statistical analyses were performed using GraphPad Prism soft-
ware (version 7). The statistical tests applied can be found in the figure
legends andMaterials andMethods section.When normal distribution
could be assumed, t test or ANOVA followed by Tukey’s test was
performed. When normal distribution could not be assumed, Mann-
Whitney test or Kruskal-Wallis test was performed. The minimum
criterion for statistical significance was P * 0.05. It should be noted that
because of the exploratory nature of our research, the P values reported
are descriptive and should not be interpreted as hypothesis testing.
Results
Development and Functional Characterization of
FRET-Based CXCR4 Sensors. To study the conforma-
tional movements that CXCR4 undergoes during ligand-
induced activation, we generated three different FRET sen-
sors for CXCR4 with modifications in different positions.
Addition of FRET-compatible fluorescent proteins or tags into
the C terminus and intracellular loops has been established
before in several GPCRs to investigate their activation
(Stumpf and Hoffmann, 2016). Conformational changes in-
duced upon ligand binding alter the distance and/or orienta-
tion between the fluorophores, resulting in changes in FRET
that can be monitored in real time (Fig. 1A). Therefore, a CFP
was fused to the C-terminal end of CXCR4, and the short
FlAsH-binding motif CCPGCC was inserted in three different
positions within the ICL-3: between L226 and S227 to
generate the CXCR4-FlAsH226-CFP sensor, between H228
and S229 to generate the CXCR4-FlAsH228-CFP sensor, or
between S229 and K230 to generate the CXCR4-FlAsH229-
CFP sensor. The receptor constructs were characterized for
correct functional properties. In particular, the CXCR4-
FlAsH228-CFP sensor was chosen for full characterization,
since it produced the highest FRET change upon agonist
binding, as shown in the following section. Analysis by
confocal microscopy showed that all three CXCR4 sensors
localized to the plasma membrane (Fig. 1B upper panel and
Supplemental Fig. 1A). Along with this, we observed that
FlAsH specifically binds to the FlAsH-binding motif in ICL-3
(Fig. 1B lower panel), as previously reported for analogous
receptor sensors (Hoffmann et al., 2005, 2010).
To investigate intramolecular FRET in the sensors, we
performed acceptor-bleaching experiments using BAL (2,3-
dimercapto-1-propanol) in cells transfected with the sensors
and FlAsH-labeled prior to the measurement. BAL displays
very high affinity for arsenicals and, at high concentrations,
displaces FlAsH from its binding site. Addition of 5 mMBAL
led to a decrease in the FlAsH signal and dequenched CFP,
proving the existence of basal intramolecular FRET (Supplemental
Fig. 2A). FRET efficiency was calculated based on the
increase in the CFP emission and was determined to be
12.0%6 3.0% (mean6 S.D.) for the CXCR4-FlAsH228-CFP
sensor (Fig. 1C). The constructs CXCR4-FlAsH226-CFP
and CXCR4-FlAsH229-CFP showed FRET efficiencies of
5.0%6 2.7% and 16.5%6 4.3%, respectively (Supplemental
Fig. 1B). No basal intermolecular FRET was detected in
cells coexpressing CXCR4-CFP and CXCR4-FlAsH228
(Supplemental Fig. 2B), which indicates that the observed
signal results from intramolecular FRET and not from
crosstalk between adjacent receptors or between protomers
of a dimer.
We then characterized the constructs for their ability to
induce G protein signaling in response to CXCL12, since they
contain the FlAsH-binding sequence in ICL-3, a region gen-
erally known to be important for G protein interaction (Hu
et al., 2010; Chung, 2013). For this purpose, we used a FRET-
based Gi1 sensor that measures G protein activation as
a change in FRET between the labeled Ga and Gg subunits
(van Unen et al., 2016). HEK293 cells cotransfected with the
Gi1 sensor and either CXCR4 or CXCR4-FlAsH228 were
stimulated with increasing concentrations of CXCL12 in
a 96-well plate assay format. Results showed that CXCR4-
FlAsH228 preserves the ability to activate Gi1 (EC50 = 15.5
[9.3–25.9] nM; mean and asymmetric 95% CI) although with
lower potency than the wild-type (wt) receptor (EC50 = 3.4
[2.3–4.9] nM; Fig. 1D). The CXCR4-FlAsH226 and CXCR4-
FlAsH229 constructs also activated Gi1 with very similar
potencies to CXCR4-FlAsH228 (EC50 = 18.1 [5.3–62.2] and
17.1 [4.9–59.3] nM, respectively; Supplemental Fig. 1C). Sub-
sequently, and to examine the functionality of the complete
sensor, we assessed the capacity of CXCL12 to inhibit FSK-
induced cAMP accumulation in cells expressing CXCR4-
FlAsH228-CFP in comparisonwith cells expressingCXCR4-CFP
or the wt receptor. The results showed that cells expressing the
sensor exhibited lower potency for the inhibition of FSK-induced
cAMP production (EC50 = 19.0 [3.5–102.7] nM) in comparison
with the wt (EC50 = 2.2 [0.6–8.0] nM). We also noted that the
presence of CFP at the end of the C terminus contributes to an
intermediate potency of the sensor with regards to Gi signaling
(EC50 = 10.6 [1.9–57.9] nM) (Fig. 1E). Most importantly, the
maximal activity of the sensorwas comparable to thewt receptor.
On the basis of this validation, these three constructs can serve
as sensors to monitor ligand-induced intramolecular conforma-
tional changes.
The FRET-Based CXCR4 Sensors Report the Dynam-
ics and Kinetics of Receptor Activation and Deactiva-
tion. The CXCR4 sensors were used for further FRET
experiments in single cells. To investigate the conformational
changes upon receptor activation, HEK293 cells transiently
expressing the receptor sensors andFlAsH-labeled prior to the
measurements were stimulated with 30 mM CXCL12. A
saturating concentration of ligand is required to determine
the maximal and fastest kinetics of the process as well as to
ensure that ligand diffusion to receptors is not time-limiting. A
BioPen microfluidic device (Fluicell) was employed for deliver-
ing the solutions. This perfusion system allows the precise












targeting of one or a few cells without affecting the surrounding
environment (Ainla et al., 2010, 2012; Wright et al., 2018). A
more detailed description of the stimulation andwash-out steps
is described in the Materials and Methods section.
Stimulation of cells expressing the CXCR4-FlAsH228-CFP
sensor with CXCL12 induced a rapid increase in the FlAsH
signal and a simultaneous decrease in the CFP signal, which
led to an increase in the FRET ratio by 2%–5% (2.8% 6 0.7%;
mean 6 S.D.) (Fig. 2, A and B; Supplemental Fig. 1G). Using
this sensor, activation of CXCR4 occurredwith a time constant
t = 590 (440–710) milliseconds (median and IQR) in response
to CXCL12 (Fig. 2, C and D). Similar responses were observed
when the CXCR4-FlAsH226-CFP and CXCR4-FlAsH229-CFP
sensors were used to resolve the kinetics of receptor activation
[t = 600 (360–820) and t = 530 (400–660) milliseconds,
respectively; Supplemental Fig. 1D]. However, the amplitudes
of the ligand-induced FRET signals with these two sensors
were smaller than with CXCR4-FlAsH228-CFP (2.1% 6
0.6% for CXCR4-FlAsH226-CFP and 1.7% 6 0.6% for
CXCR4-FlAsH229-CFP; Supplemental Fig. 1, E–G). After
stimulation, rapid superfusion of the cells with buffer
removed the ligand, and the FRET signal returned to baseline,
allowing the off-kinetics of the receptor to be determined.
Deactivation of CXCR4 after CXCL12 stimulation occurred with
t = 20.7 (11.6–27.1) seconds (Fig. 2E). In summary, these sensors
faithfullymonitor the ligand-induced structural rearrangements
Fig. 1. Principle and functional characterization of the CXCR4-FlAsH228-CFP sensor. (A) Schematic depicting the intramolecular FRET-based sensor.
Ligand-induced conformational changes in CXCR4 are monitored as changes in FRET. (B) Representative confocal images of HEK293 cells transiently
expressing CXCR4-FlAsH228-CFP and FlAsH-labeled prior to the measurement. Upper panel shows CFP emission. Lower panel shows FlAsH emission.
Scale bar, 10 mm. (C) Intramolecular FRET efficiency of CXCR4-FlAsH228-CFP as determined by BAL treatment. Values were calculated from the
increase in the CFP fluorescence uponBAL addition. Data showsmean6S.D. of 20 cellsmeasured on 4 independent experimental days. A representative
individual experiment is shown in Supplemental Fig. 2. (D) Gi1 activation via CXCR4 or CXCR4-FlAsH228 in response to increasing concentrations of
CXCL12. Data showmean6 S.E.M. and are representative of n = 3 independent experiments conducted in quadruplicate. In this particular experiment,
EC50 = 3.3 and 14.7 nM for CXCR4 and CXCR4-FlAsH228, respectively. (E) Inhibition of FSK-induced cAMP accumulation in response to increasing
concentrations of CXCL12 by HEK293T cells expressing CXCR4, CXCR4-CFP, or CXCR4-FlAsH228-CFP. Data show mean 6 S.E.M. and are
representative of n = 4 independent experiments conducted in triplicate. In this particular experiment, EC50 = 7.3, 11.3, and 39.0 nM for CXCR4, CXCR4-
CFP, and CXCR4-FlAsH228-CFP, respectively. Characterization of the CXCR4-FlAsH226-CFP and CXCR4-FlAsH229-CFP sensors is presented in
Supplemental Fig. 1. RLU, relative light unit.












within the TM domain that reflect the activation of the receptor
and have shown that the CXCL12-induced activation of CXCR4
is slower in comparison with other class A GPCRs and more
similar to the activation of the class B PTHR.
CXCR4 and Gi Proteins Remain within FRET Dis-
tance in the Absence of Agonist. Generally, activation of
aGPCR results in the recruitment of G proteins to the agonist-
bound receptor. To determine the speed of coupling, we
employed the constructs CXCR4-YFP and Gg2-CFP, which
are coexpressed with the Gai1 and Gb1 subunits for proper
stoichiometry and localization of the G proteins to the plasma
membrane (Fig. 3A). Surprisingly, and in contrast to what has
been described for most GPCRs (Hein et al., 2005, 2006;
Ferrandon et al., 2009; Hoffmann et al., 2012), stimulation of
CXCR4 with CXCL12 (30 mM) resulted in a decrease in the
FRET signal with an amplitude of 3.3 6 1.0% (Fig. 3C). This
rearrangement occurred at a speed of t = 960 (870–980)
milliseconds (Fig. 3E). To further investigate this effect, we
examined the interaction of CXCR4-YFP with the G protein
CFP-labeled at Gai1 (Gai1-CFP) (Fig. 3B). Again, a decrease in
the agonist-dependent FRET signal was detected upon re-
ceptor activation with an amplitude of 2.7% 6 0.9% (Fig. 3D)
and at a speed of t = 1030 (750–1320) milliseconds (Fig. 3E).
Whether receptors are preassembledwithG proteins or only
associate upon agonist exposure is still a matter of debate and,
so far, it seems to be dependent on the specific receptor/G
protein pair (Hein and Bünemann, 2009; Andressen et al.,
2018). To further study a potential interaction of CXCR4 with
the Gi protein in the absence of agonist, we performed acceptor
photobleaching experiments in cells expressing CXCR4-YFP,
Gg2-CFP, Gb1, and Gai1 (Fig. 4A). In parallel, the YFP-labeled
a2A-AR was tested under the same conditions. CFP and YFP
emission intensities were measured prior to and after photo-
bleaching the YFP, and the changes detected in the FCFP were
quantified. After photobleaching, no significant increase in
FCFP was detected with the a2A-AR-YFP [DFCFP = 0.4 (21.0 to
1.1) %; median and IQR; Fig. 4, B and C], in agreement with
published data (Hein et al., 2005). In contrast, a significant
increase in FCFP was detected with CXCR4-YFP [DFCFP = 2.0
(1.0–3.1) %; Fig. 4, B and D], indicating the existence of basal
energy transfer prior to the photobleaching process. When
such cells were treated with 10 mM of the small molecule IT1t
(antagonist), no significant change in FCFP upon YFP photo-
bleaching was detected [DFCFP = 0.4 (20.4 to 1.2) %; Fig. 4, B
and E]. These findings suggest that although there is no
specific interaction between a2A-AR and the Gi proteins in the
Fig. 2. The CXCR4-FlAsH228-CFP sensor reports the dynamics and kinetics of receptor activation and deactivation. (A and B) Representative traces of
the FRET response from a single HEK293 cell expressing the CXCR4-FlAsH228-CFP sensor and stimulated with 30mMCXCL12 for the indicated period
of time (black line). Left panel shows corrected and normalized FRET ratio. Right panel shows corrected FlAsH (yellow) and CFP (cyan) emissions. (C)
Kinetic analysis of receptor activation. The FRET change was fitted to a one-component exponential decay function to obtain the time constant t. (D and
E) On-kinetics of CXCR4 in response to CXCL12 (D) and off-kinetics of CXCR4 upon wash-out of the ligand with buffer (E). t values from individual
experiments are represented in a scatter plot. Data showmedian and IQR of 17 cells measured on 4 independent experimental days. a.u., arbitrary units.












absence of agonist under these experimental conditions,
CXCR4 resides within FRET distance of the Gi protein, which
might reflect a potential interaction between these two
partners in the absence of agonist. Such behavior is consistent
with other studies that suggest that CXCR4 exhibits some
degree of basal receptor activity (Mishra et al., 2016; Mona
et al., 2016).
CXCR4 Induces Prolonged Gi Protein Activation in
Response to CXCL12. To investigate the kinetics of Gi
protein activation, we used FRET-based sensors for Gi1, Gi2,
and Gi3 (van Unen et al., 2016). These sensors provide a real-
time read-out for G protein activation by the loss of FRET
between the Gg- and Ga-labeled subunits in response to
agonist stimulation of the receptor (Fig. 5A). HEK293 cells
were cotransfectedwith CXCR4 or a2A-AR and one of the three
G protein sensors. Then, single cells were stimulated with the
appropriate ligand, either CXCL12 (30 mM) or norepinephrine
(100mM), using the BioPen.We detected activation of all three
G protein subtypes via both receptors in response to their
respective agonists, with no significant differences among the
G protein subtypes. Upon stimulation, an immediate decrease
in the FRET ratio was observed in every case (Fig. 5, B and C;
Supplemental Fig. 3, A–D). Interestingly, the kinetic profiles
of G protein activation via the two receptors were remarkably
different. For CXCR4, G protein activation occurred with t  4
seconds, whereas for a2A-AR, G protein activation occurred
with t 650milliseconds (Fig. 5D), which is almost an order of
magnitude faster and in agreement with published data
(Hein et al., 2005; Van Unen et al., 2016). After ligand
exposure, cells were continuously washed with buffer to
remove the ligands. In the case of the a2A-AR, washing
resulted in the FRET signal returning rapidly to baseline,
which suggests that the G proteins rapidly adopt once again
the inactive conformation upon removal of the ligand.
However, CXCL12 induced a prolonged Gi activation via
CXCR4, reflected by slower G protein off-kinetics that could
not be resolved in the time frame of the experiment (Fig. 5, B
and C, lower panels; Supplemental Fig. 3, A–D). These
observations suggest different G protein activation by these
two receptors, even though they both belong to class A
GPCRs.
Further experiments were performed in a 96-well plate
FRET reader to test the effects of CXCL12-induced CXCR4
activation on G proteins. We observed a concentration-
dependent activation of Gi1, Gi2, and Gi3 in cells expressing
CXCR4 (Fig. 5E, gray lines). The EC50 values obtained for
CXCL12 were 6.7 [2.9–15.4] nM for Gi1 activation, 9.9
[4.8–20.2] nM for Gi2 activation, and 18.6 [8.4–40.9] nM for
Fig. 3. CXCL12 induces rearrangements between CXCR4 and the Gi1 protein. (A and B) Schematic depicting the settings employed to investigate the
interaction between the receptor and the Gi1 protein. HEK293 cells were transfected with CXCR4-YFP and Gai1/Gb1/Gg2-CFP (A) or Gai1-CFP/Gb1/Gg2
(B). (C and D) Representative traces of the FRET response from a single HEK293 cell expressing CXCR4-YFP and the G protein CFP-labeled at the Gg2
(C) or Gai1 subunit (D) and stimulated with 30 mM CXCL12 for the indicated period of time (black line). Upper panels show corrected YFP (yellow) and
CFP (cyan) emissions. Lower panels show corrected and normalized FRET ratios. (E) On-kinetics of the interaction of CXCR4 with the Gi1 protein upon
CXCL12 stimulation as measured in the two settings. t values from individual experiments are represented in a scatter plot. Data showmedian and IQR
of 12 cells for each setting, measured on at least 3 independent experimental days. Statistical significance was tested using Mann-Whitney test.
a.u.,arbitrary units; n.s., nonsignificant.












Gi3 activation. Therefore, the isoforms Gi1 and Gi2 were
activated with significantly higher potency than Gi3, which
is in accordance with published data (Kleemann et al., 2008).
The EC50 values obtained are also in good agreement with the
potency of CXCL12 at CXCR4 described in other systems
(Gupta et al., 2001; Rosenkilde et al., 2004; Kleemann et al.,
2008; Levoye et al., 2009). No G protein activation was
detected in cells expressing the G protein sensors but not
CXCR4 (Fig. 5E, black data points; controls for Gi2 and Gi3 not
shown). Although the CXCL12/CXCR4 axis has also been
shown to activate Gq proteins in some contexts (Soede et al.,
2001; Shi et al., 2007), we did not detect activation of Gq using
a FRET-based Gq sensor (Fig. 5E, brown data points; Adjobo-
Hermans et al., 2011).
Since our data suggest a potential interaction between
CXCR4 and G proteins in the absence of agonist, we next
analyzed the effects of IT1t versus those of CXCL12 on the Gi2
FRET sensor in CXCR4-expressing cells. FRET was analyzed
under different conditions: buffer treatment, 100 mM IT1t
treatment, or 100 nM CXCL12 treatment. We observed that
IT1t caused a significantly higher FRET, and CXCL12 caused
a significantly lower FRET compared with buffer (Fig. 5F).
These data support the notion that CXCR4 activates G
proteins in the absence of agonist or, in other words, that it
exhibits some degree of basal receptor activity that can be
blocked by IT1t, thus suggesting that this molecule would act
as inverse agonist on CXCR4.
CXCR4 Homodimer Rearrangement Kinetically Pre-
cedes G Protein Activation. Despite the fact that GPCR
monomers have been demonstrated to be functional units
(Whorton et al., 2007), increasing evidence has emerged for
a functional role of dimers and higher oligomeric structures
(Milligan et al., 2019). Therefore, we next investigated the
kinetics of the rearrangement that occurs between CXCR4
protomers upon binding of CXCL12. To do so, HEK293 cells
were transfected with CXCR4-CFP and CXCR4-YFP and
stimulated with the agonist CXCL12, again using the BioPen
(Fig. 6A).
Upon stimulation of single cells with CXCL12 (30 mM),
a large increase in the FRET signal was detected with an
amplitude of 7.5%6 2.8%,which suggests an approximation of
the two fluorophores in the active state of the receptor
(Fig. 6B). Interestingly, this rearrangement occurred at
a speed of t = 1660 (1370–2010) milliseconds (Fig. 6C), which
indicates that this movement is achieved faster than the
activation of the G proteins. Upon wash-out of the ligand
with buffer, the signal returned to baseline, which allowed
the determination of the off-kinetics of this process to be t =
34.1 (21.3–36.1) seconds (Fig. 6D). Altogether, these data
suggest that changes in CXCR4 homodimer occur slower
than activation of a CXCR4 protomer. In contrast to our
observations for CXCR4, several reports demonstrated that
for the class C mGluR1, intersubunit rearrangements
between protomers precedes intrasubunit rearrangements
Fig. 4. CXCR4 resides within FRET distance from Gi proteins in the absence of agonist. (A) Schematic of acceptor photobleaching experiments. Donor
and acceptor emissions were measured prior to and after photobleaching the YFP in HEK293 cells expressing the constructs Gai1/Gb1/Gg2-CFP and a2A-
AR-YFP or CXCR4-YFP. The latter was also measured in the presence of IT1t. (B) The change in the FCFP after YFP photobleaching from individual
experiments in each condition is shown as a box plot. N = 19, 13, and 12 cells for CXCR4, CXCR4 + IT1t, and a2A-AR, respectively, measured on 3
independent experimental days. Statistical significance was tested using unpaired t test (***P # 0.001; ****P # 0.0001). (C–E) Representative CFP
(cyan) and YFP (yellow) traces from individual experiments. The YFP photobleaching period is indicated in gray. a.u., arbitrary units.












(Hlavackova et al., 2012; Grushevskyi et al., 2019). This
distinct behavior might be related to the different nature of
the receptor dimers and might be a characteristic activation
feature of class C GPCRs, for which dimerization is oblig-
atory for function (Kniazeff et al., 2011; Zhang et al., 2014).
MIF Induces Distinct Structural Rearrangements in
CXCR4 and Does Not Activate Gi Proteins. MIF has
been recently described to be able to bind and signal via
CXCR4 as a partial agonist (Rajasekaran et al., 2016).
Therefore, the settings that have been earlier established in this
work to investigate the CXCL12-induced activation of CXCR4
were employed to investigate each step of the transduction
pathway of this receptor in response to MIF. During the
measurements, single cells expressing the construct(s) of interest
were stimulated with 100 mMMIF, followed by a short wash-out
with buffer and subsequent stimulation with 30 mM CXCL12.
First, receptor activation was investigated in cells trans-
fected with the CXCR4-FlAsH228-CFP sensor and FlAsH-
labeled prior to the measurement. In contrast to CXCL12,
which produced an increase in the FRET signal, MIF binding
to the sensor led to a decrease in the FRET ratio at a speed of t
= 270 (250–440) milliseconds (Fig. 7, A and B). This suggests
different conformational changes in CXCR4 by these two
ligands.Washing of the cells with buffer afterMIF stimulation
rapidly returned the FRET signal to baseline, indicating that
MIF can be easily removed from the receptor and suggesting
a low ligand affinity. Subsequent stimulation with CXCL12
produced a response that was indistinguishable from the
response observed when cells were directly stimulated with
CXCL12, indicating that this response is not affected by the
prior stimulation of the cells with MIF (Supplemental Fig.
4A). Second, the interaction of CXCR4 with the Gi protein was
Fig. 5. CXCR4 activates Gi proteins in response to CXCL12. (A) FRET-based sensors for Gi1, Gi2, Gi3, andGqwere employed to studyG protein activation.
A loss of FRET between the Gg-Venus and Ga-mTurquoise2 subunits is detected upon activation. (B and C) Representative traces of the FRET response
from a single HEK293 cell expressing the Gi2 sensor and CXCR4 (B) or a2A-AR (C) and stimulated with 30 mM CXCL12 or 100 mM norepinephrine,
respectively (black line). Upper panels show corrected Venus (yellow) and mTurquoise2 (cyan) emissions. Lower panels show corrected and normalized
FRET ratios. Supplemental Fig. 3 shows activation of Gi1 and Gi3. (D) Kinetics of Gi1, Gi2, and Gi3 protein activation via CXCR4 or a2A-AR in response to
CXCL12 and norepinephrine, respectively. Table shows median and IQR. t values from individual experiments are represented in a scatter plot with
median and IQR. For CXCR4, n = 11, 22, and 11 cells for Gi1, Gi2, and Gi3 activation, respectively, measured on at least 3 independent experimental days.
For a2A-AR, n = 17, 16, and 7 cells for Gi1, Gi2, and Gi3 activation, respectively, measured on at least 2 independent experimental days. Statistical
significance was tested using Kruskal-Wallis test. n.s., nonsignificant. (E) CXCR4-mediated activation of Gi1, Gi2, Gi3, and Gq activation in response to
increasing concentrations of CXCL12. As a control, empty plasmid was transfected instead of receptor. Data showmean6 S.E.M. and are representative
of n = 5 independent experiments conducted in quadruplicate. In this particular experiment, EC50 values were 9.7, 10.8, and 17.1 nM for Gi1, Gi2, and Gi3,
respectively. (F) FRET of cells expressing the CXCR4 and Gi2 sensor upon treatment with buffer, buffer supplemented with 100 mM IT1t or 100 nM
CXCL12. Data are representative of three independent experiments. Data show mean6 S.D. and are normalized to buffer treatment.N = 30, 30, and 15
wells (containing 15,000 cells each) for the treatment with buffer, IT1t, and CXCL12, respectively. Statistical significance was tested using unpaired t test
(**P # 0.01; ****P # 0.0001). a.u., arbitrary units.












examined in cells transfected with CXCR4-YFP and the G
protein CFP-labeled at the Gg2 subunit. Upon stimulation
withMIF, an increase in the FRET signal was observed with t
= 380 (300–560) milliseconds (Fig. 7, C and D). Thus, again,
MIF produced a response that is opposite to that of CXCL12,
suggesting that the rearrangement of the Gi protein with
CXCR4 is different when the receptor is bound to MIF and
CXCL12 and further supports the idea that the receptor
adopts distinct conformations when bound to these two
ligands. Upon washing of the cells with buffer, the FRET
signal rapidly returned to baseline, and the cells could be
subsequently stimulated with CXCL12, inducing a similar
response to when cells are directly stimulated with this ligand
(Supplemental Fig. 4B). Third, we investigated the movement
between CXCR4 protomers upon MIF binding in cells trans-
fected with CXCR4-CFP and CXCR4-YFP. We observed an
MIF-induced decrease in the FRET signal that occurred at
a speed of t = 870 (580–930) milliseconds (Fig. 7, E and F).
Again, the signal induced by MIF moved in the opposite
direction, indicating once again different conformational
changes in the receptor induced by these two ligands. The
response induced by CXCL12 was also not affected by prior
stimulation of the cells with MIF (Supplemental Fig. 4C).
Fourth, cells transfected with CXCR4 and the Gi2 sensor were
employed to investigate receptor-mediated G protein activa-
tion. Surprisingly, stimulation of the cells with MIF did not
result in a change in FRET in the G protein sensor (Fig. 7G),
indicating a lack of CXCR4-mediated G protein activation in
response to this ligand. As a positive control, subsequent
stimulation of the same cells with CXCL12 led to the
activation of the G protein. A summary of the kinetics of
CXCR4 activation and signaling in response to MIF in
comparison with CXCL12 is shown in Fig. 7H.
Discussion
The temporal resolution of individual biochemical steps
that comprise a signaling cascade is important to understand
cellular signaling. In this study, we report the kinetic and
dynamic properties of early activation events in the CXCR4
transduction pathway in response to CXCL12 andMIF. Based
on knownmovements of the TM domains that occur in GPCRs
upon activation (Latorraca et al., 2017), we developed FRET-
based sensors that are able to faithfully report the ligand-
induced conformational changes in CXCR4. These constructs
localize to the plasma membrane and preserve the ability to
activate G proteins (Fig. 1), representing the first FRET
sensors developed in the field of chemokine receptors.
The CXCR4 FRET sensors exhibited activation kinetics of
t  600 milliseconds in response to binding of the peptide
agonist CXCL12 (Fig. 2). This is considerably slower than
other class A receptors in response to small molecules,
Fig. 6. CXCR4 homodimers undergo con-
formational changes in response to
CXCL12. (A) The rearrangement between
CXCR4 protomers was investigated in
HEK293 cells cotransfected with CXCR4-
CFP and CXCR4-YFP, with the fluoro-
phores fused to the C termini. (B)
Representative traces of the FRET re-
sponse from a single HEK293 cell express-
ing CXCR4-YFP and CXCR4-CFP and
stimulated with 30 mM CXCL12 (black
line). Upper panel shows corrected YFP
(yellow) and CFP (cyan) emissions. Lower
panel shows corrected and normalized
FRET ratio. (C and D) On-kinetics of the
rearrangement between CXCR4 proto-
mers in response to CXCL12 (C) and off-
kinetics upon wash-out of the ligand with
buffer (D). t alues from individual experi-
ments are represented in a scatter plot
with median and IQR.N = 28 and 10 cells,
respectively, measured on 4 independent
experimental days. a.u., arbitrary units.












which exhibit activation time constants in the range of 2–50
milliseconds (Vilardaga et al., 2003; Hoffmann et al., 2005;
Rochais et al., 2007; Reiner et al., 2010; Ziegler et al., 2011;
Grushevskyi et al., 2019). Interestingly, CXCL12-induced
activation of CXCR4 occurred in the same time range as the
activation kinetics determined for the class B PTHR in
response to the peptide PTH(1–34) (t  1 second; Vilardaga
et al., 2003). These differences in the activation kinetics
might depend on intrinsic properties of the receptors, the
type of ligand, and its binding mode. In this case, the
Fig. 7. MIF induces structural rearrangements in CXCR4 but does not lead to Gi protein activation. (A, C, E, and G) Representative traces of the FRET
response from a singleHEK293 cell transiently expressing: CXCR4-FlAsH228-CFP sensor (A), CXCR4-YFP andGai1/Gb1/Gg2-CFP (C), CXCR4-CFP and
CXCR4-YFP (E) or CXCR4 and Gi2 sensor (G), which were stimulated with 100 mMMIF and then followed by wash-out and then stimulation with 30 mM
CXCL12. Upper panels show corrected acceptor (yellow) and donor (cyan) emissions. Lower panels show corrected and normalized FRET ratios. (B, D,
and F) On-kinetics of receptor activation (n = 9 cells) (B), receptor/G protein interaction (n = 13 cells) (D) and rearrangement between CXCR4 protomers
(n = 17 cells) (F) in response to 100 mMMIF. t values from individual experiments are represented in a scatter plot with median and IQR. Measurements
were performed on at least 2 independent experimental days. (H) Comparison of CXCR4 on-kinetics in response to CXCL12 andMIF. Data from receptor
activation belong to Figs. 2D and 7B. Data from receptor/G protein interaction belong to Figs. 3E (Gg-labeled) and 7D. Data from protomers
rearrangement belong to Figs. 6C and 7F. Data from G protein activation belong to Fig. 5D (Gi2 sensor). Data are shown as a box plot in which the
whiskers represent maximum and minimum values. a.u., arbitrary units.












binding of chemokines to their chemokine receptors pro-
ceeds via a complex mechanism that involves the formation
of an extensive protein-protein interface with multiple
recognition sites throughout the receptor (Wu et al., 2010;
Kleist et al., 2016; Gustavsson et al., 2017). Likewise,
PTH(1–34) was described to bind in two steps to PTHR
(Castro et al., 2005).
The next signaling step we investigated led to the in-
teresting observation of a decrease in the FRET signal
between CXCR4-YFP and the CFP-labeled G protein upon
CXCL12 stimulation (Fig. 3). Most receptors tested using this
setting reported an increase in the FRET signal upon agonist
stimulation, which is interpreted as G protein recruitment by
the receptor (Hein et al., 2005, 2006). A recent study compar-
ing the propensity of the two serotonin receptors 5-HT4 and 5-
HT7 to associate with G proteins showed that 5-HT7 preasso-
ciates with Gs, whereas 5-HT4 interacts with Gs in an agonist-
dependentmanner. Respectively, a decrease and increase in the
FRET signals were detected (Andressen et al., 2018). Accord-
ingly, our data might suggest that CXCL12 stimulation of
CXCR4 does not lead to recruitment of the G protein but rather
to a rearrangement or dissociation of a preformed complex.
The spontaneous ligand-independent transition of GPCRs
between inactive and active conformations is called basal or
constitutive activity and is a common property of wt GPCRs
but can also be a result of receptor mutations, which can cause
a variety of diseases (Seifert and Wenzel-Seifert, 2002). Our
results suggest a significant degree of basal activity for
CXCR4. Photobleaching experiments in cells expressing
CXCR4-YFP and CFP-labeled Gi1 protein showed a ligand-
independent energy transfer between these two proteins
(Fig. 4). Although the nature of their interaction is unknown,
these data suggest close proximity or potential interaction
between CXCR4 and the Gi protein prior to agonist stimula-
tion. This hypothesis is further supported by the basal
activation of Gi proteins observed in the presence of CXCR4,
which was abolished by addition of IT1t, hence indicating
inverse agonist properties for this compound (Fig. 4; Fig. 5F).
Considering that an estimated 85% of antagonists turn out to
be inverse agonists when tested in contexts in which receptors
exhibit constitutive activity (Kenakin, 2004), it is not surpris-
ing that IT1t, which has been considered a CXCR4 antagonist
until now, exhibits inverse agonist properties in our assays.
Although our findings indicate that CXCR4 exhibits constitu-
tive activity (at least in regard to G protein signaling),
stimulation of the cells with CXCL12 further activated G
proteins, thus indicating that this activity was not saturated.
The existence of basal CXCR4 activity is in agreement with
observations in previous studies (Mishra et al., 2016; Mona
et al., 2016). Since overexpression of CXCR4 has been widely
reported for a large number of cancers and other pathologies
(Müller et al., 2001; Balkwill, 2004; Darash-Yahana et al.,
2004; Chatterjee et al., 2014b; Zhao et al., 2015), the degree of
spontaneous activity might reach a significant level in these
contexts and become therapeutically relevant. On the basis of
our observations, the degree of basal activity of CXCR4 should
be validated in such pathophysiological systems and in vivo.
An in-depth understanding of the biology of CXCR4 in this
respect should assist in the design of improved CXCR4-
targeting drugs.
Whenmeasuring G protein activation, wemade an intriging
observation related to the G protein off-kinetics. Even after
persistent wash-out of CXCL12 from the receptor, CXCR4-
mediated G protein activation remained for a long time
(Fig. 5B), whereas this was not the case for the norepineph-
rine/a2A-AR axis (Fig. 5C) or other ligand/receptor pairs tested
using these same G protein sensors (van Unen et al., 2016;
Oehler et al., 2017; Grundmann et al., 2018). The nature of
this observation is currently unknown to us, but several
factors might play a role in this process. A possible explana-
tion might be related to ligand residence time that might
contribute to prolonged signaling (Hoffmann et al., 2015;
Hothersall et al., 2016). Compared with norepinephrine and
a2A-AR, CXCL12 remains bound to CXCR4 for a significantly
longer time period. This assumption is based on our observed
slower CXCR4 off-kinetics upon CXCL12 stimulation and
wash-out with buffer, which was roughly 21 seconds (Fig. 2E),
hence approximately 10 times slower than the a2A-AR sensor
(Hein et al., 2005). However, this deactivation of the CXCR4
receptor was still much faster than the G protein deactivation.
Alternatively, the different receptors might induce distinct
active conformations of the G protein, which would display
different lifetimes and GTPase activities (Furness et al., 2016).
To mechanistically explain these differences in G protein off-
kinetics, further research is required.
Our study provides insights into the distinctmechanisms by
which MIF and CXCL12 regulate the activity of CXCR4 and
presents evidence for their different pharmacological proper-
ties. Our data indicate that binding of CXCL12 and MIF
induces distinct structural rearrangements in CXCR4, which
can be distinguished dynamically and kinetically at each step
of the signaling cascade (Fig. 7). This suggests different
binding modes of these two ligands to the same receptor, as
proposed by other studies (Rajasekaran et al., 2016; Lacy
et al., 2018). The extensive interaction interface between
CXCL12 and CXCR4 involves interactions between the core
of the ligand and the receptor N terminus as well as the ligand
N terminus with the receptor TM cavity (Qin et al., 2015). In
contrast, MIF binds to the N-terminal region of CXCR4 at
different residues than CXCL12 and not within the TM cavity
(Rajasekaran et al., 2016). Their different binding modes are
also supported by the incomplete displacement of CXCL12
from CXCR4 by MIF (Supplemental Fig. 5; Bernhagen et al.,
2007). Furthermore, and in line with our distinct FRET
signals (MIF opposite to CXCL12) but in contrast to other
studies, we did not detect Gi protein activation via CXCR4 in
response to MIF (Fig. 7G). Although our observations would
suggest inverse agonist properties for MIF, functional data in
other studies show thatMIF acts as a CXCR4 allosteric partial
agonist and mediates at least some of its functions via Gi
proteins (Bernhagen et al., 2007; Klasen et al., 2014;
Rajasekaran et al., 2016). A possible explanation for these
distinct observations could be the cellular context. Although
MIF can bind to CXCR4 alone, its binding and function appear
to be facilitated by the presence of the single-pass membrane-
receptor CD74 (cluster of differentiation 74), which together
with CXCR4 forms a functional high-affinity heteromeric
complex for MIF (Bernhagen et al., 2007; Schwartz et al.,
2009; Klasen et al., 2014). HEK293 cells lack endogenous
expression of CD74 (Schwartz et al., 2009), and, in our
experiments, MIF was rapidly washed away from the receptor
upon addition of buffer (Fig. 7, A, C, and E). The presence of
CXCR4/CD74 complexes might be crucial in determining MIF
signaling. For example, in platelets, which lack CD74, MIF












could bind to CXCR4 but did not lead to extracellular signal-
regulated kinase phosphorylation, whereas MIF-induced ex-
tracellular signal-regulated kinase phosphorylation was
detected in monocytes, which express both receptors (Chatterjee
et al., 2014a).
In summary, we provide kinetic data from ensemble
measurements for the early signaling steps of the human
chemokine receptor CXCR4. Upon CXCL12 engagement,
structural rearrangements within the TM domain (t  600
milliseconds) are kinetically followed by rearrangements
between CXCR4 and the G protein in the intracellular side
that occur at a speed of t  1 seconds. Furthermore,
a structural rearrangement between CXCR4 protomers
occurs with t  1.7 seconds, whereas G protein activation
by CXCR4 finally occurs with t  4 seconds. These kinetic
events are summarized in Fig. 8. It is tempting to speculate
that the rearrangement between protomers precedes G
protein activation and to suggest that conformational
changes in CXCR4 homodimers, when present, play a possible
role in the signaling activation course of this receptor as depicted
in model B. However, we need to emphasize that mechanistic
interpretation needs to be based on measuring microscopic rate
constants, and hence, model A, in which dimer rearrangement
offers analternativepathway, is also compatiblewith our dataset.
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Fig. 8. Summary of the findings in this manuscript regarding the CXCL12/CXCR4 axis. The upper part of the figure shows the kinetics of each step of the
signaling cascade investigated using FRET. The main findings regarding the CXCL12/CXCR4 axis are: 1) Activation kinetics of CXCR4 upon CXCL12
binding are slower than other class A GPCRs; 2) Rearrangements within dimers occur faster than activation of Gi proteins; 3) This axis leads to
a prolonged activation of Gi proteins; and 4) CXCR4 exhibits some degree of constitutive activity. It is tempting to speculate that the rearrangement
between protomers precedes G protein activation, which might suggest that conformational changes in CXCR4 homodimers, when present, play
a possible role in the signaling activation course of this receptor as depicted in model B. However, we need to emphasize that mechanistic interpretation
needs to be based onmeasuring microscopic rate constants, and hence, model A, in which the dimer rearrangement offers an alternative pathway, is also
compatible with our dataset. a.u., arbitrary units.













Participated in research design: Perpiñá-Viciano, Zarca, Kilpatrick,
Hoffmann.
Conducted experiments: Perpiñá-Viciano, Zarca, Caspar,
Kilpatrick.
Performed data analysis: Perpiñá-Viciano, Zarca, Caspar,
Kilpatrick.
Wrote or contributed to the writing of the manuscript: Perpiñá-
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Figure S1. Characterization of the CXCR4-FlAsH226-CFP and CXCR4-FlAsH229-CFP sensors. (A) 
Representative confocal images showing CFP fluorescence in HEK293 cells transiently expressing 
CXCR4-FlAsH226-CFP (upper panel) and CXCR4-FlAsH229-CFP (lower panel). Scale bars represent 10 
µm. (B) Intramolecular FRET efficiency of CXCR4-FlAsH226-CFP and CXCR4-FlAsH229-CFP, as 
measured by BAL treatment. Data shows mean ± SD of 13 and 18 cells, respectively, measured on 3 
independent experimental days. (C) Gi1 activation via CXCR4, CXCR4-FlAsH226 or CXCR4-FlAsH229 
in response to increasing concentrations of CXCL12. Data show mean ± SEM and are representative of 
n=3 independent experiments conducted in quadruplicate. In this particular experiment, EC50 = 19.3 and 
21.4 nM for CXCR4-FlAsH226 and CXCR4-FlAsH229, respectively. Data showed for CXCR4 is from 
Figure 1D. (D) On-kinetics of CXCR4 in response to CXCL12 as measured with CXCR4-FlAsH226-CFP 
and CXCR4-FlAsH229-CFP. Tau values from individual experiments are represented in a scatter plot. Data 
show the median and IQR of 7 and 14 cells measured on 4 independent experimental days, respectively. 
(E-F) Representative traces of the FRET response from a single HEK293 cell expressing CXCR4-
FlAsH226-CFP (D) or CXCR4-FlAsH229-CFP (E) and stimulated with 30 µM CXCL12. Upper panels 
show corrected FlAsH (yellow) and CFP (cyan) emissions. Lower panels show corrected and normalized 
FRET ratios. (G) Amplitude of the FRET signal detected with each of the sensors upon stimulation with 
30 µM CXCL12. Mean ± SD is shown. 









Figure S2. Determination of the intra- and intermolecular FRET efficiency of the CXCR4-FlAsH228-
CFP sensor. The existence of basal energy transfer was determined by BAL treatment. Raw data of 
representative experiments is shown. (A) Basal intramolecular FRET of the CXCR4-FlAsH228-CFP 
sensor. Pooled data is shown in Figure 1C. (B) Basal intermolecular FRET when CXCR4-CFP and CXCR4-












Figure S3. Activation of Gi1 and Gi3 via CXCR4 or α2A-AR upon stimulation with their respective 
ligands, CXCL12 and norepinephrine. (A-D) Representative traces of the FRET response from a single 
HEK293 cell transiently expressing: Gi1 sensor and CXCR4 (A), Gi3 sensor and CXCR4 (B), Gi1 sensor 













Figure S4. CXCL12-induced CXCR4 responses are not affected by prior stimulation of the cells with 
MIF. On-kinetics of receptor activation (A), receptor/G protein interaction (B) and rearrangement between 
CXCR4 protomers (C) in response to 30 µM CXCL12 with or without prior stimulation with 100 µM MIF. 
For CXCL12 response after MIF stimulation, data shows the median and IQR of 8 cells for receptor 
activation measured on 2 independent experimental days, 13 cells for receptor/G protein interaction 
measured on 4 independent experimental days, and 14 cells for protomers rearrangement measured on 3 
independent experimental days. Data for single CXCL12 stimulation from A, B and C has been taken from 
figure 2D, 3E, and 6C, respectively. Statistical significance was tested using Mann-Whitney test (n.s.=non-
significant). 
  








Figure S5. Competition of CXCL12 with 
MIF for binding to CXCR4. Experiments 
were performed in HEK293G cells stably 
expressing NLuc-CXCR4. CXCL12-
AlexaFluor647 fluorescent ligand (10nM) was 
displaced with increasing concentrations of 
unlabeled CXCL12, MIF or AMD3100. Data 
show mean ± SEM of n=5-6 independent 
experiments. 
